Calls
7
#456
Alpha Score 58.5
Yoo Chi-yang
CEO
Win Rate
100.0%
return
+3.2%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 03
$1579000.00
+5.8%
SK hynix and Samsung Electronics are not to be sold on this pullback. The weekend news flow was net positive (long-term supply deals, AI narratives, potential shareholder returns), and the sell-off looks like post-surge profit-taking. The 5-day moving average is about to flatten and turn up, and short covering could drive the next leg higher.
AI Memory
Long
Aug 03
$240500.00
+3.3%
SK hynix and Samsung Electronics are not to be sold on this pullback. The weekend news flow was net positive (long-term supply deals, AI narratives, potential shareholder returns), and the sell-off looks like post-surge profit-taking. The 5-day moving average is about to flatten and turn up, and short covering could drive the next leg higher.
AI Memory
Long
Aug 03
$108000.00
+0.7%
SPG is showing a unique chart pattern among beaten-down stocks—it has already broken above near-term resistance and is making higher highs and higher lows in a weak tape, signaling genuine institutional interest and potential to lead if the market stabilizes.
Robotics
Long
Aug 03
$181600.00
+1.0%
Large-cap biotech names like Samsung Biologics and Celltrion are making higher highs and are poised to break out further. They are the stronger names within biotech, offering a less speculative way to capture the sector rotation that is underway.
Pharma & Biotech
Long
Aug 03
$4885.00
+3.8%
Global Tax Free is attempting to break through a key resistance level that has contained it for weeks. A successful breakout would signal a change in character and could trigger accelerated upside within the duty-free/tax-refund theme.
Construction & Infrastructure
Long
Aug 03
$1413000.00
+4.5%
Large-cap biotech names like Samsung Biologics and Celltrion are making higher highs and are poised to break out further. They are the stronger names within biotech, offering a less speculative way to capture the sector rotation that is underway.
Pharma & Biotech
Long
Aug 03
$372000.00
+3.4%
PharmaResearch exhibits the same strength pattern as SPG: it is climbing with higher lows after a steep decline and appears ready to challenge prior highs. This relative strength in a difficult market suggests durable buying pressure.
Pharma & Biotech
Showing 7 of 7 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Yoo Chi-yang has 7 trade ideas tracked on Buzzberg across 7 tickers since August 2026. Ranked #456 on the Buzzberg Alpha leaderboard. Most covered: 000660.KS, 005930.KS, 214450.KQ.
